Apple Health Health Connect How GLP-1 users use SNAQ Logging smaller meals quickly with a photo when appetite is low and manual entry feels like too much Tracking protein intake across the day to stay above a target when overall eating is reduced Saving meals and snacks that work well as Favorites for one-tap re-logging Seeing the scale move alongside what you ate, with weight pulled in automatically from Apple Health or Health Connect Connecting CGM data to see how food and glucose patterns interact during dose escalation Asking the AI Nutritionist about meal composition and nutrition balance in plain language Maintaining a food history to share with a dietitian or prescribing doctor at appointments SNAQ is backed by published clinical evidence in diabetes, including peer-reviewed research in Type 1 diabetes and photo-based carb estimation
Peptides, by virtue of their role in supporting natural hormone production, are often viewed as a more ethical alternative when used in a medical setting
LifeWave Stats & Patented Tech Founded in 2004 Open in over 70 countries X39 pre-launched in 2018 with official launch in early 2019 Company growth from 20 million to $600 million (2020-2024) 3,000% growth rate from 2018-2024 Worlds fastest growing direct sales company Our purpose is to empower you to live in the light, maximizing your human potential, with patented life technology that enhances your life. X39 is a fully patented new technology LifeWave patches are an FDA recognized and compliant General Wellness Product Over 80 clinical studies on all the patches Not a me too product like most companies that sell weight loss, supplements, oils, etc
Moreover, inhibiting PI3K/Akt signaling abolished the protective effects of GLP-1R by increase the apoptosis activity and ER stress
Zepbound revenue soared from $175.8 million to $1.9 billion, while Mounjaro sales jumped 60% to $3.5 billion
